drugset / Trial / NCT00028327
Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
RandomizedFactorialOpen-labelTreatment
Summary
Many HIV infected patients admitted to the intensive care area (ICA) have never taken anti-HIV drugs. The purpose of this study is to learn whether starting anti-HIV drugs while patients are in an ICA will help them to survive and get better faster. This study will also evaluate patients who, though not in an ICA, have been admitted to the hospital for serious illnesses or infections.
Timeline
- Start
- —
- Primary completion
- 2004-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | — | — |
| Subject | Lamivudine | Other / unclassified | — | — |
| Subject | Nelfinavir | Other / unclassified | — | — |
| Subject | Zidovudine | Small molecule | — | — |